The Landmark Series: Hilar Cholangiocarcinoma

Hilar cholangiocarcinoma (HC) is a rare and highly aggressive biliary tract neoplasm. As such, the data driving the management of this disease generally are not based on prospective clinical trial data but rather consist of retrospective experiences and limited level 1 data. Surgical resection offers the best chance of a long-term survival, but local and distant recurrences are common. This report presents landmark articles that form the basis of preoperative, operative, and adjuvant strategies for HC.

Automated summary

Hilar cholangiocarcinoma is a rare and highly aggressive biliary tract neoplasm, with management strategies based on retrospective experiences and limited data. Surgical resection offers the best chance for long-term survival, although local and distant recurrences are common.